Eplivanserin

DRUG2 trials

Sponsors

Sanofi

Conditions

InsomniaPrimary InsomniaSleep Initiation and Maintenance Disorders

Phase 3

Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia

CompletedNCT00253968

SanofiInsomnia, Sleep Initiation and Maintenance Disorders

Start: 2005-11-30End: 2008-01-31Updated: 2016-03-01

Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties

CompletedNCT00805350

SanofiPrimary Insomnia

Start: 2008-12-31End: 2009-06-30Updated: 2016-03-07